Observatory of Patients With Metastatic ProstAte Adenocarcinoma That is Resistant to Castration and Multi-LinE Strategies

N/AActive Not RecruitingNCT03611686

University Hospital, Rouen219 enrolled

Overview

Evaluation the overall survival of patients with metastatic prostate adenocarcinoma resistant to castration

Study Type

OBSERVATIONAL

Enrollment

219

Conditions

Metastatic Prostate Adenocarcinoma

Interventions

Local chemotherapyDRUG

Local chemotherapy will be administrated according to local recommendation

Eligibility

Sex: MALEMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patient monitored for castration-resistant metastatic prostate * Patients starting a first or second line treatment as part of castration resistance * Patient not objecting to the study after reading the information letter * Patient aged over 18 years Exclusion Criteria: * Patient monitored for non-metastatic prostate cancer * Patient monitored for castration-nonresistant prostate cancer * Patient not able to understand the information letter

Locations (1)

Rouen University Hospital

Rouen, France

Outcomes

Primary Outcomes

Number of alive patient

Time frame: 3 years

Secondary Outcomes

Number of alive patient disease free

Time frame: 3 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.